(GLAD) Gladstone Capital - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3765358789
Stock: Senior Debt, Second-Lien, Subordinated, Equity
Total Rating 19
Risk 50
Buy Signal -0.49
| Risk 5d forecast | |
|---|---|
| Volatility | 24.8% |
| Relative Tail Risk | 4.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.33 |
| Alpha | -40.77 |
| Character TTM | |
|---|---|
| Beta | 0.511 |
| Beta Downside | 0.644 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.61% |
| CAGR/Max DD | 0.23 |
EPS (Earnings per Share)
Revenue
Description: GLAD Gladstone Capital March 01, 2026
Gladstone Capital Corporation (NASDAQ: GLAD) is a Business Development Company (BDC) that focuses on providing growth-capital and debt financing to lower-middle-market U.S. companies across a broad range of industries, including business services, specialty manufacturing, energy, healthcare, and aerospace & defense. The firm typically invests $8-$40 million of debt in companies with $20-$150 million of revenue and $3-$25 million of EBITDA, favoring minority equity stakes and employing buy-and-build, add-on acquisition, and refinancing strategies.
As of the latest quarter (Q4 2025), GLAD reported a net asset value (NAV) of $13.45 per share and a dividend yield of roughly 8.2%, reflecting its BDC-required 90% distribution policy. The portfolio remains heavily weighted toward senior debt (about 70% of assets) with the remainder in mezzanine and equity positions, and the average loan size sits near $20 million. In the current credit environment, rising interest rates have tightened middle-market lending, positioning GLAD to capture higher spreads while its diversified industry exposure mitigates sector-specific risk.
For a deeper dive, you might explore ValueRay’s analyst notes on GLAD.
Headlines to watch out for
- Interest rate fluctuations impact loan portfolio profitability
- Credit quality of small and medium-sized businesses affects defaults
- Regulatory changes for BDCs influence operational costs
- Economic downturns reduce demand for corporate financing
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 36.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -9.04 > 1.0 |
| NWC/Revenue: -300.7% < 20% (prev 3.55%; Δ -304.3% < -1%) |
| CFO/TA -0.02 > 3% & CFO -23.0m > Net Income 36.9m |
| Net Debt (401.7m) to EBITDA (36.9m): 10.89 < 3 |
| Current Ratio: 0.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.4m) vs 12m ago 27.13% < -2% |
| Gross Margin: 63.85% > 18% (prev 0.83%; Δ 6.30k% > 0.5%) |
| Asset Turnover: 6.74% > 50% (prev 15.55%; Δ -8.81% > 0%) |
| Interest Coverage Ratio: 1.74 > 6 (EBITDA TTM 36.9m / Interest Expense TTM 21.2m) |
Altman Z'' -1.11
| A: -0.19 (Total Current Assets 16.6m - Total Current Liabilities 192.7m) / Total Assets 922.8m |
| B: -0.03 (Retained Earnings -24.3m / Total Assets 922.8m) |
| C: 0.04 (EBIT TTM 36.9m / Avg Total Assets 869.2m) |
| D: -0.06 (Book Value of Equity -24.3m / Total Liabilities 416.3m) |
| Altman-Z'' Score: -1.11 = CCC |
Beneish M
| DSRI: 1.72 (Receivables 6.96m/8.75m, Revenue 58.6m/126.8m) |
| GMI: 1.30 (GM 63.85% / 83.11%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.46 (Revenue 58.6m / 126.8m) |
| TATA: 0.06 (NI 36.9m - CFO -23.0m) / TA 922.8m) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of GLAD shares?
As of March 24, 2026, the stock is trading at USD 17.65 with a total of 392,656 shares traded.
Over the past week, the price has changed by +0.01%, over one month by -1.65%, over three months by -10.03% and over the past year by -29.84%.
Over the past week, the price has changed by +0.01%, over one month by -1.65%, over three months by -10.03% and over the past year by -29.84%.
Is GLAD a buy, sell or hold?
Gladstone Capital has received a consensus analysts rating of 3.33.
Therefor, it is recommend to hold GLAD.
- StrongBuy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GLAD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.7 | 22.8% |
| Analysts Target Price | 21.7 | 22.8% |
GLAD Fundamental Data Overview March 22, 2026
P/E Trailing = 11.1203
P/E Forward = 11.0497
P/S = 4.3302
P/B = 0.8574
P/EG = 2.3116
Revenue TTM = 58.6m USD
EBIT TTM = 36.9m USD
EBITDA TTM = 36.9m USD
Long Term Debt = 213.2m USD (estimated: total debt 405.9m - short term 192.7m)
Short Term Debt = 192.7m USD (from shortTermDebt, last quarter)
Debt = 405.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 401.7m USD (from netDebt column, last quarter)
Enterprise Value = 798.7m USD (397.0m + Debt 405.9m - CCE 4.17m)
Interest Coverage Ratio = 1.74 (Ebit TTM 36.9m / Interest Expense TTM 21.2m)
EV/FCF = -34.76x (Enterprise Value 798.7m / FCF TTM -23.0m)
FCF Yield = -2.88% (FCF TTM -23.0m / Enterprise Value 798.7m)
FCF Margin = -39.23% (FCF TTM -23.0m / Revenue TTM 58.6m)
Net Margin = 62.98% (Net Income TTM 36.9m / Revenue TTM 58.6m)
Gross Margin = 63.85% ((Revenue TTM 58.6m - Cost of Revenue TTM 21.2m) / Revenue TTM)
Gross Margin QoQ = 52.81% (prev 71.74%)
Tobins Q-Ratio = 0.87 (Enterprise Value 798.7m / Total Assets 922.8m)
Interest Expense / Debt = 1.46% (Interest Expense 5.93m / Debt 405.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 29.1m (EBIT 36.9m * (1 - 21.00%))
Current Ratio = 0.09 (Total Current Assets 16.6m / Total Current Liabilities 192.7m)
Debt / Equity = 0.80 (Debt 405.9m / totalStockholderEquity, last quarter 506.5m)
Debt / EBITDA = 10.89 (Net Debt 401.7m / EBITDA 36.9m)
Debt / FCF = -17.49 (negative FCF - burning cash) (Net Debt 401.7m / FCF TTM -23.0m)
Total Stockholder Equity = 491.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 36.9m / Total Assets 922.8m)
RoE = 7.50% (Net Income TTM 36.9m / Total Stockholder Equity 491.8m)
RoCE = 5.23% (EBIT 36.9m / Capital Employed (Equity 491.8m + L.T.Debt 213.2m))
RoIC = 3.56% (NOPAT 29.1m / Invested Capital 819.4m)
WACC = 4.43% (E(397.0m)/V(802.9m) * Re(7.78%) + D(405.9m)/V(802.9m) * Rd(1.46%) * (1-Tc(0.21)))
Discount Rate = 7.78% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 14.19%
[DCF] Fair Price = unknown (Cash Flow -23.0m)
EPS Correlation: 88.99 | EPS CAGR: 20.30% | SUE: 0.54 | # QB: 0
Revenue Correlation: 42.60 | Revenue CAGR: 0.31% | SUE: -0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-09-30): EPS=1.93 | Chg7d=-0.011 | Chg30d=-0.011 | Revisions Net=+0 | Growth EPS=-4.4% | Growth Revenue=+12.9%
EPS next Year (2027-09-30): EPS=1.91 | Chg7d=-0.014 | Chg30d=-0.014 | Revisions Net=+4 | Growth EPS=-1.3% | Growth Revenue=+5.0%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.1% (Discount Rate 7.9% - Earnings Yield 9.0%)
[Growth] Growth Spread = +18.6% (Analyst 17.5% - Implied -1.1%)
P/E Forward = 11.0497
P/S = 4.3302
P/B = 0.8574
P/EG = 2.3116
Revenue TTM = 58.6m USD
EBIT TTM = 36.9m USD
EBITDA TTM = 36.9m USD
Long Term Debt = 213.2m USD (estimated: total debt 405.9m - short term 192.7m)
Short Term Debt = 192.7m USD (from shortTermDebt, last quarter)
Debt = 405.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 401.7m USD (from netDebt column, last quarter)
Enterprise Value = 798.7m USD (397.0m + Debt 405.9m - CCE 4.17m)
Interest Coverage Ratio = 1.74 (Ebit TTM 36.9m / Interest Expense TTM 21.2m)
EV/FCF = -34.76x (Enterprise Value 798.7m / FCF TTM -23.0m)
FCF Yield = -2.88% (FCF TTM -23.0m / Enterprise Value 798.7m)
FCF Margin = -39.23% (FCF TTM -23.0m / Revenue TTM 58.6m)
Net Margin = 62.98% (Net Income TTM 36.9m / Revenue TTM 58.6m)
Gross Margin = 63.85% ((Revenue TTM 58.6m - Cost of Revenue TTM 21.2m) / Revenue TTM)
Gross Margin QoQ = 52.81% (prev 71.74%)
Tobins Q-Ratio = 0.87 (Enterprise Value 798.7m / Total Assets 922.8m)
Interest Expense / Debt = 1.46% (Interest Expense 5.93m / Debt 405.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = 29.1m (EBIT 36.9m * (1 - 21.00%))
Current Ratio = 0.09 (Total Current Assets 16.6m / Total Current Liabilities 192.7m)
Debt / Equity = 0.80 (Debt 405.9m / totalStockholderEquity, last quarter 506.5m)
Debt / EBITDA = 10.89 (Net Debt 401.7m / EBITDA 36.9m)
Debt / FCF = -17.49 (negative FCF - burning cash) (Net Debt 401.7m / FCF TTM -23.0m)
Total Stockholder Equity = 491.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.24% (Net Income 36.9m / Total Assets 922.8m)
RoE = 7.50% (Net Income TTM 36.9m / Total Stockholder Equity 491.8m)
RoCE = 5.23% (EBIT 36.9m / Capital Employed (Equity 491.8m + L.T.Debt 213.2m))
RoIC = 3.56% (NOPAT 29.1m / Invested Capital 819.4m)
WACC = 4.43% (E(397.0m)/V(802.9m) * Re(7.78%) + D(405.9m)/V(802.9m) * Rd(1.46%) * (1-Tc(0.21)))
Discount Rate = 7.78% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 14.19%
[DCF] Fair Price = unknown (Cash Flow -23.0m)
EPS Correlation: 88.99 | EPS CAGR: 20.30% | SUE: 0.54 | # QB: 0
Revenue Correlation: 42.60 | Revenue CAGR: 0.31% | SUE: -0.53 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=-0.002 | Chg30d=-0.002 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-09-30): EPS=1.93 | Chg7d=-0.011 | Chg30d=-0.011 | Revisions Net=+0 | Growth EPS=-4.4% | Growth Revenue=+12.9%
EPS next Year (2027-09-30): EPS=1.91 | Chg7d=-0.014 | Chg30d=-0.014 | Revisions Net=+4 | Growth EPS=-1.3% | Growth Revenue=+5.0%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.1% (Discount Rate 7.9% - Earnings Yield 9.0%)
[Growth] Growth Spread = +18.6% (Analyst 17.5% - Implied -1.1%)